RIZATRIPTAN-MEDIS rizatriptan (as benzoate) 10 mg orodispersible tablet blister pack

Pays: Australie

Langue: anglais

Source: Department of Health (Therapeutic Goods Administration)

Ingrédients actifs:

rizatriptan benzoate, Quantity: 14.53 mg (Equivalent: rizatriptan, Qty 10 mg)

Disponible depuis:

Medis Pharma Pty Ltd

DCI (Dénomination commune internationale):

rizatriptan benzoate

forme pharmaceutique:

Tablet, orally disintegrating

Composition:

Excipient Ingredients: aspartame; microcrystalline cellulose; colloidal anhydrous silica; crospovidone; magnesium stearate; mannitol; calcium silicate; Flavour

Mode d'administration:

Oral

Unités en paquet:

3, 2, 6

Type d'ordonnance:

(S4) Prescription Only Medicine

indications thérapeutiques:

RIZATRIPTAN-MEDIS is indicated for the acute treatment of migraine attacks with or without aura.

Descriptif du produit:

Visual Identification: White, round, flat, bevel-edged tablet embossed with "IZ 10" on one side and plain on the other side; Container Type: Blister Pack; Container Material: PA/Al/PVC/Al - polyamide-aluminium foil-polyvinylchloride/aluminium foil; Container Life Time: 36 Months; Container Temperature: Store below 30 degrees Celsius

Statut de autorisation:

Licence status A

Date de l'autorisation:

2015-02-19